
- Pharmaceutical Technology, October 2022
- Volume 46
- Issue 10
- Pages: 12
Next-Generation Synthetic Biology Workflow Platform
Codex DNA’s BioXp 9600 system is designed for the automated synthesis of synthetic biology workflows.
Codex DNA’s BioXp 9600 system is a next-generation high throughput platform intended for automated synthesis of gene fragments and clones from digital sequences. Designed for use with synthetic biology workflows, the system provides overnight, automated synthesis of genes, clones, DNA libraries, and mRNA. It is capable of processing up to 96 gene fragments overnight.
The system features a unique instrument design that is intended to minimize benchtop footprint while also increasing throughput and versatility. Proprietary error correction and Gibson assembly technology automate the identification and removal of mismatches introduced during synthesis and assembly.
Articles in this issue
almost 4 years ago
Adopting Smart Development Strategiesalmost 4 years ago
Application of F Charts in Continued Process Verification of OSD Formsalmost 4 years ago
Reformulating Successalmost 4 years ago
Analyzing Extractables and Leachables in Single-Use Systemsalmost 4 years ago
Improving Sterility Using Blow-Fill-Seal Technologyalmost 4 years ago
Electrochemistry for API Synthesisalmost 4 years ago
Shining a Light on Lipid Nanoparticle Characterizationalmost 4 years ago
The Future of Drug Delivery for Biopharmaceuticalsalmost 4 years ago
The State of Contamination Controlalmost 4 years ago
Biologic Standards in the Pharmacopoeias: An Update



